Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126063291 | 12606329 | 1 | I | 2015 | 20160706 | 20160729 | 20160729 | PER | US-PFIZER INC-2016334607 | PFIZER | 50.00 | YR | M | Y | 0.00000 | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126063291 | 12606329 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, THREE TIMES A DAY OR TWICE A DAY | Y | 20235 | 300 | MG | CAPSULE, HARD | ||||||
| 126063291 | 12606329 | 2 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | UNK | 0 | |||||||||||
| 126063291 | 12606329 | 3 | C | COREG | CARVEDILOL | 1 | Oral | 12.5 MG, 2X/DAY | 0 | 12.5 | MG | TABLET | BID | ||||||
| 126063291 | 12606329 | 4 | C | COREG | CARVEDILOL | 1 | 0 | TABLET | |||||||||||
| 126063291 | 12606329 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 80 MG, 2X/DAY | 0 | 80 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126063291 | 12606329 | 1 | Neuropathy peripheral |
| 126063291 | 12606329 | 2 | Blood pressure abnormal |
| 126063291 | 12606329 | 3 | Blood pressure abnormal |
| 126063291 | 12606329 | 4 | Cardiac failure |
| 126063291 | 12606329 | 5 | Diuretic therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126063291 | 12606329 | Condition aggravated | |
| 126063291 | 12606329 | Drug ineffective for unapproved indication | |
| 126063291 | 12606329 | Urinary incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126063291 | 12606329 | 1 | 2015 | 201511 | 0 | |
| 126063291 | 12606329 | 2 | 2013 | 0 | ||
| 126063291 | 12606329 | 3 | 2013 | 0 | ||
| 126063291 | 12606329 | 5 | 2013 | 0 |